Saluda Medical Pty Limited, a medical device company developing a platform of closed-loop neuromodulation technologies based on neural response to stimulation, has secured A$53 million ($40 million) in an all-equity financing round.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
